IMNM Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 8.60%

Insider Buying (Last 12 Months): $3,425,760.18

Insider Selling (Last 12 Months): $279,313.12

Immunome Insider Trading History Chart

Immunome Share Price & Price History

^$7.91

▲ +0.74 (10.32%)

As of 04/17/2025 05:00 PM ET

Days: 30 | 90 | 365

Immunome Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/26/2025	Clay B Siegall	CEO	Buy	137,100	$7.29	$999,459.00	806,736
3/24/2025	Jean Jacques Bienaime	Director	Buy	7,000	$8.21	$57,470.00	23,615
3/24/2025	Philip Tsai	CTO	Buy	12,300	$8.42	$103,566.00	33,300
1/31/2025	Clay B Siegall	CEO	Buy	150,000	$7.75	$1,162,500.00	669,636
11/21/2024	Clay B Siegall	CEO	Buy	66,057	$9.54	$630,183.78	485,693
11/21/2024	Philip Tsai	CTO	Buy	21,000	$9.43	$198,030.00	21,000
11/21/2024	Robert Lechleider	Insider	Buy	15,805	$9.48	$149,831.40	15,805
9/19/2024	Max Rosett	CFO	Sell	14,380	$16.01	$230,223.80	47,476
8/16/2024	Jean Jacques Bienaime	Director	Buy	7,000	$13.94	$97,580.00	16,615
8/15/2024	Jack Higgins	Insider	Sell	3,524	$13.93	$49,089.32	16,000
5/21/2024	Jean Jacques Bienaime	Director	Buy	2,000	$13.57	$27,140.00	9,615
10/2/2023	Bruce Turner	Insider	Buy	42,300	$5.91	$249,993.00	42,300
10/2/2023	Clay B Siegall	CEO	Buy	169,204	$5.91	$999,995.64	319,636

See Full Table

SEC Filings (Institutional Ownership Changes) for Immunome (NASDAQ:IMNM)

44.58% of Immunome stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Immunome Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
4/16/2025	Wealth Enhancement Advisory Services LLC	51,544	$0.35M	0.0%	+24.2%	0.059%
4/8/2025	Rhumbline Advisers	88,888	$0.60M	0.0%	+30.4%	0.102%
4/7/2025	GAMMA Investing LLC	6,138	$0.41M	0.0%	+2,822.9%	0.007%
3/24/2025	Wellington Management Group LLP	145,564	$1.55M	0.0%	+3.5%	0.182%
3/17/2025	Wealth Enhancement Advisory Services LLC	41,505	$0.44M	0.0%	+5.1%	0.052%
2/17/2025	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	58,193	$0.62M	0.0%	+32.7%	0.073%
2/17/2025	Woodline Partners LP	980,925	$10.42M	0.1%	+6.1%	1.230%
2/17/2025	Squarepoint Ops LLC	17,914	$0.19M	0.0%	-43.5%	0.022%
2/17/2025	Two Sigma Advisers LP	48,200	$0.51M	0.0%	N/A	0.060%
2/17/2025	Two Sigma Investments LP	154,467	$1.64M	0.0%	N/A	0.194%
2/17/2025	Rafferty Asset Management LLC	81,391	$0.86M	0.0%	-6.5%	0.102%
2/17/2025	Redmile Group LLC	4,828,026	$51.27M	3.6%	-1.3%	6.052%
2/17/2025	Point72 Asset Management L.P.	688,790	$7.32M	0.0%	+46.3%	0.863%
2/17/2025	ProShare Advisors LLC	14,477	$0.15M	0.0%	N/A	0.018%
2/17/2025	Prosight Management LP	54,342	$0.58M	0.2%	+38.9%	0.068%
2/17/2025	Nuveen Asset Management LLC	186,087	$1.98M	0.0%	-1.6%	0.233%
2/17/2025	Northeast Financial Consultants Inc	42,953	$0.46M	0.0%	-41.1%	0.054%
2/17/2025	Millennium Management LLC	158,428	$1.68M	0.0%	N/A	0.199%
2/17/2025	Janus Henderson Group PLC	3,455,939	$36.73M	0.0%	-0.9%	4.332%
2/17/2025	Granahan Investment Management LLC	314,239	$3.34M	0.1%	N/A	0.394%
2/17/2025	Enavate Sciences GP LLC	3,478,261	$36.94M	26.5%	N/A	4.360%
2/17/2025	Deutsche Bank AG	46,075	$0.49M	0.0%	+50.8%	0.058%
2/17/2025	Crestline Management LP	24,744	$0.26M	0.0%	N/A	0.031%
2/17/2025	Cubist Systematic Strategies LLC	84,930	$0.90M	0.0%	N/A	0.106%
2/17/2025	Bank of America Corp DE	43,917	$0.47M	0.0%	-50.1%	0.055%
2/17/2025	BNP Paribas Financial Markets	6,584	$70K	0.0%	N/A	0.008%
2/14/2025	Jane Street Group LLC	18,153	$0.19M	0.0%	-64.8%	0.023%
2/14/2025	Northern Trust Corp	516,491	$5.49M	0.0%	+9.1%	0.647%
2/14/2025	The Manufacturers Life Insurance Company	189,060	$2.01M	0.0%	+14.2%	0.237%
2/14/2025	Aquatic Capital Management LLC	8,935	$95K	0.0%	N/A	0.011%
2/14/2025	Voya Investment Management LLC	15,600	$0.17M	0.0%	-8.4%	0.020%
2/14/2025	Adage Capital Partners GP L.L.C.	500,000	$5.31M	0.0%	+127.3%	0.627%
2/14/2025	T. Rowe Price Investment Management Inc.	5,499,954	$58.41M	0.0%	-4.5%	6.894%
2/14/2025	Price T Rowe Associates Inc. MD	2,282,754	$24.24M	0.0%	+12.1%	2.861%
2/14/2025	Tower Research Capital LLC TRC	8,608	$91K	0.0%	+482.0%	0.011%
2/14/2025	MetLife Investment Management LLC	35,619	$0.38M	0.0%	+17.7%	0.045%
2/13/2025	Marshall Wace LLP	1,216,182	$12.92M	0.0%	-17.1%	1.524%
2/13/2025	Barclays PLC	104,314	$1.11M	0.0%	-1.5%	0.131%
2/13/2025	Kennedy Capital Management LLC	14,521	$0.15M	0.0%	N/A	0.018%
2/13/2025	Raymond James Financial Inc.	25,817	$0.27M	0.0%	N/A	0.032%
2/13/2025	Renaissance Technologies LLC	316,000	$3.36M	0.0%	+2,696.5%	0.396%
2/13/2025	Legal & General Group Plc	41,993	$0.45M	0.0%	-17.3%	0.053%
2/13/2025	Invesco Ltd.	26,661	$0.28M	0.0%	-93.8%	0.033%
2/13/2025	Wells Fargo & Company MN	26,207	$0.28M	0.0%	+45.5%	0.033%
2/12/2025	Geode Capital Management LLC	1,228,851	$13.05M	0.0%	+1.8%	1.540%
2/12/2025	Wellington Management Group LLP	145,564	$1.55M	0.0%	+3.5%	0.182%
2/12/2025	JPMorgan Chase & Co.	648,610	$6.89M	0.0%	+2,540.4%	0.813%
2/11/2025	Corebridge Financial Inc.	25,556	$0.27M	0.0%	-7.0%	0.032%
2/11/2025	Vanguard Group Inc.	3,003,438	$31.90M	0.0%	-4.1%	3.765%
2/11/2025	KLP Kapitalforvaltning AS	7,100	$75K	0.0%	N/A	0.009%
2/11/2025	Virtu Financial LLC	45,743	$0.49M	0.0%	N/A	0.057%
2/11/2025	Teacher Retirement System of Texas	11,648	$0.12M	0.0%	N/A	0.015%
2/11/2025	Intech Investment Management LLC	18,961	$0.20M	0.0%	+26.5%	0.024%
2/10/2025	Corient Private Wealth LLC	12,085	$0.13M	0.0%	-50.1%	0.015%
2/10/2025	Commonwealth Equity Services LLC	19,017	$0.20M	0.0%	N/A	0.024%
2/7/2025	Sequoia Financial Advisors LLC	19,065	$0.20M	0.0%	+11.7%	0.031%
2/7/2025	AlphaQuest LLC	7,868	$84K	0.0%	+786,700.0%	0.013%
2/6/2025	Raymond James Financial Inc.	25,817	$0.27M	0.0%	N/A	0.041%
2/6/2025	Charles Schwab Investment Management Inc.	457,252	$4.86M	0.0%	+3.3%	0.733%
2/4/2025	Johnson Financial Group LLC	20,000	$0.21M	0.0%	N/A	0.032%
2/4/2025	Los Angeles Capital Management LLC	35,721	$0.38M	0.0%	N/A	0.057%
2/4/2025	Bank of New York Mellon Corp	123,203	$1.31M	0.0%	-1.4%	0.197%
2/3/2025	Handelsbanken Fonder AB	200,000	$2.12M	0.0%	-13.0%	0.320%
1/29/2025	Three Bridge Wealth Advisors LLC	27,615	$0.29M	0.1%	N/A	0.044%
1/28/2025	Stoneridge Investment Partners LLC	11,554	$0.12M	0.0%	N/A	0.019%
1/24/2025	Scharf Investments LLC	44,389	$0.47M	0.0%	N/A	0.071%
1/17/2025	Magnus Financial Group LLC	53,536	$0.57M	0.1%	+107.8%	0.086%
12/26/2024	JPMorgan Chase & Co.	24,565	$0.36M	0.0%	+6.6%	0.039%
12/13/2024	Lord Abbett & CO. LLC	450,280	$6.58M	0.0%	+4.1%	0.721%
11/19/2024	Barclays PLC	105,886	$1.55M	0.0%	+125.9%	0.170%
11/16/2024	Geode Capital Management LLC	1,207,455	$17.66M	0.0%	+13.6%	2.011%
11/15/2024	Barclays PLC	105,886	$1.55M	0.0%	+125.9%	0.176%
11/15/2024	XTX Topco Ltd	24,823	$0.36M	0.0%	N/A	0.041%
11/15/2024	Wellington Management Group LLP	140,690	$2.06M	0.0%	+137.1%	0.234%
11/15/2024	State Street Corp	2,187,466	$31.98M	0.0%	-7.5%	3.642%
11/15/2024	Point72 Asset Management L.P.	470,647	$6.88M	0.0%	+22.2%	0.784%
11/15/2024	Janus Henderson Group PLC	3,488,121	$50.97M	0.0%	+10.3%	5.808%
11/14/2024	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	43,865	$0.64M	0.0%	-15.7%	0.073%
11/14/2024	MetLife Investment Management LLC	30,265	$0.44M	0.0%	+129.1%	0.050%
11/13/2024	FMR LLC	4,224,700	$61.77M	0.0%	+0.3%	7.035%
11/13/2024	The Manufacturers Life Insurance Company	165,491	$2.42M	0.0%	-0.9%	0.276%
11/12/2024	Cerity Partners LLC	53,103	$0.78M	0.0%	+10.5%	0.088%
11/12/2024	Charles Schwab Investment Management Inc.	442,477	$6.47M	0.0%	+217.0%	0.737%
11/9/2024	Primecap Management Co. CA	280,800	$4.11M	0.0%	+4.5%	0.468%
11/9/2024	Intech Investment Management LLC	14,987	$0.22M	0.0%	N/A	0.025%
11/5/2024	Victory Capital Management Inc.	730,785	$10.68M	0.0%	+48.1%	1.217%
10/24/2024	Wealth Enhancement Advisory Services LLC	39,500	$0.58M	0.0%	-5.0%	0.066%
10/3/2024	SG Americas Securities LLC	72,627	$1.06M	0.0%	-19.8%	0.121%
9/16/2024	Cubist Systematic Strategies LLC	19,421	$0.24M	0.0%	-73.6%	0.032%
8/19/2024	Point72 Asset Management L.P.	385,067	$4.66M	0.0%	-76.5%	0.642%
8/16/2024	Northeast Financial Consultants Inc	72,953	$0.88M	0.0%	N/A	0.122%
8/15/2024	The Manufacturers Life Insurance Company	166,928	$2.02M	0.0%	+52.2%	0.278%
8/15/2024	AQR Capital Management LLC	16,064	$0.19M	0.0%	+34.6%	0.027%
8/15/2024	AXA S.A.	179,688	$2.17M	0.0%	N/A	0.300%
8/14/2024	Squarepoint Ops LLC	73,929	$0.90M	0.0%	-38.3%	0.123%
8/14/2024	Cubist Systematic Strategies LLC	19,421	$0.24M	0.0%	-73.6%	0.032%
8/14/2024	Marshall Wace LLP	1,713,325	$20.73M	0.0%	+228.5%	2.857%
8/14/2024	Profund Advisors LLC	21,629	$0.26M	0.0%	N/A	0.036%
8/13/2024	Ensign Peak Advisors Inc	113,934	$1.38M	0.0%	N/A	0.190%
8/13/2024	Sei Investments Co.	12,538	$0.15M	0.0%	-34.0%	0.021%

Data available starting January 2016

See Full Table

Immunome, Inc., a biotechnology company, develops targeted cancer therapies. The company's clinical asset comprises AL102, an investigational gamma secretase inhibitor currently in evaluation in a Phase 3 trial for the treatment of desmoid tumors; and preclinical assets consist of IM-1021, a receptor tyrosine kinase-like orphan receptor 1 and antibody-drug conjugates, as well as IM-3050, a fibroblast activation protein targeted radioligand therapy; and IM-4320, an anti-IL-38 immunotherapy candidate. Immunome, Inc. was incorporated in 2006 and is based in Bothell, Washington.

Today's Range

Now: $7.91

$6.97

$7.96

50 Day Range

MA: $8.24

$5.56

$10.43

52 Week Range

Now: $7.91

$5.15

$17.97

Volume

1,493,908 shs

Average Volume

907,981 shs

Market Capitalization

$687.78 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.05

Who are the company insiders with the largest holdings of Immunome?: Immunome's top insider shareholders include:
Clay B Siegall (CEO)
Max Rosett (CFO)
Bruce Turner (Insider)
Philip Tsai (CTO)
Jean Jacques Bienaime (Director)
Jack Higgins (Insider)
Robert Lechleider (Insider)
Learn More about top insider investors at Immunome.
Who are the major institutional investors of Immunome?: Immunome's top institutional investors include:
Rhumbline Advisers — 0.10%
Wealth Enhancement Advisory Services LLC — 0.06%
GAMMA Investing LLC — 0.01%
Learn More about top institutional investors of Immunome stock.
Which institutional investors are buying Immunome stock?: In the last quarter, IMNM stock was bought by institutional investors including:
Rhumbline Advisers
Wealth Enhancement Advisory Services LLC
GAMMA Investing LLC
During the previous year, these company insiders have bought Immunome stock:
Clay B Siegall (CEO)
Max Rosett (CFO)
Bruce Turner (Insider)
Philip Tsai (CTO)
Jean Jacques Bienaime (Director)
Learn More investors buying Immunome stock.